Kate Gifford 
The Defocus Incorporated Multiple Segments (DIMS) clinical study included a two year randomized controlled trial, which then extended to investigate continued efficacy over six years of wear, plus groups who switched from single vision to DIMS and back again. There was no evidence of a rebound effect. Visual acuity and binocular visual functions were similar across groups.
Professor Dominique Bremond-Gignac is the Head of Ophthalmology at University Hospital Necker-Enfants Malades of Paris Cité University in Paris, France. In this interview, we chatted with her about her experiences of combination treatment; in particular, with prescribing HOYA MiYOSMART spectacle lenses and atropine for children with myopia.
A new study has shown that an ‘extra compression factor’ of 1D, which is essentially increasing the treatment target, improved myopia control outcomes for children wearing orthokeratology. This would seem to indicate a different approach is needed for myopia control, but delving into the study reveals the story is not that simple.
Repeated low-level red light (RLRL) therapy is showing impressive results for myopia control in children, with a two-year randomized controlled trial showing highly impressive results for slowing and even reversing axial elongation. While reported as safe, a new case report suggests otherwise. Read more about this red hot topic here.
These two studies argue different sides of whether the 20/20 rule of regular breaks from near work can support myopia management, while also investigating other factors involved in digital eye strain such as dry eye symptoms and binocular vision function.
Data from up to six years of wear in the landmark MiSight® 1 day clinical trial has shown similar outcomes for comfort, vision, handling and overall satisfaction compared to children wearing Proclear® 1 day single vision lenses. Children 11-15 years who were refit from single vision to MiSight 1 day also rated lenses highly and increased their contact lens wearing time.
This study examined rates of corneal infiltrative (or inflammatory) events, including microbial keratitis, in nine studies. Most study data was for children fitted at 12 years of age or younger and most wore daily disposables. Taking in data for almost 3,000 children and over 6,000 patient-years of wear, rates were found to be low, adding to the body of evidence that children appear to be safer soft contact lens wearers than adults.
We asked some key atropine questions of myopia thought leader Professor Mark Bullimore, who has published numerous landmark papers in the field, including his newest on the inconsistencies found in compounded atropine. Learn about the present and the future of atropine treatment for childhood myopia.
How do A-scan and optical biometry compare? How many measurements should you take and how frequently? Learn about instruments, measurement processes and how to use data on axial length in myopia management.
The HOYA MiYOSMART was the first of the new generation of myopia control spectacle lenses, with evidence for slowing myopia progression by at least half. Learn more about efficacy, the lens design, visual outcomes and more.
